Browsing by Author "Čivčić, Milorad (18436145000)"
Now showing 1 - 5 of 5
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Altered daytime fluctuation pattern of plasminogen activator inhibitor 1 in type 2 diabetes patients with coronary artery disease: A strong association with persistently elevated plasma insulin, increased insulin resistance, and abdominal obesity(2015) ;Lalić, Katarina (13702563300) ;Jotić, Aleksandra (13702545200) ;Rajković, Nataša (13702670500) ;Singh, Sandra (16022873000) ;Stošić, Ljubica (57205884711) ;Popović, Ljiljana (7004316275) ;Lukić, Ljiljana (24073403700) ;Miličić, Tanja (24073432600) ;Seferović, Jelena P. (23486982900) ;Maćešić, Marija (26967836100) ;Stanarčić, Jelena (59663037000) ;Čivčić, Milorad (18436145000) ;Kadić, Iva (56674542000)Lalić, Nebojša M. (13702597500)This study was aimed at investigating daily fluctuation of PAI-1 levels in relation to insulin resistance (IR) and daily profile of plasma insulin and glucose levels in 26 type 2 diabetic (T2D) patients with coronary artery disease (CAD) (group A), 10 T2D patients without CAD (group B), 12 nondiabetics with CAD (group C), and 12 healthy controls (group D). The percentage of PAI-1 decrease was lower in group A versus group B (4.4 ± 2.7 versus 35.0 ± 5.4%; P<0.05) and in C versus D (14.0 ± 5.8 versus 44.7 ± 3.1%; P<0.001). HOMA-IR was higher in group A versus group B (P<0.05) and in C versus D (P<0.01). Simultaneously, AUCs of PAI-1 and insulin were higher in group A versus group B (P<0.05) and in C versus D (P<0.01), while AUC of glucose did not differ between groups. In multiple regression analysis waist-to-hip ratio and AUC of insulin were independent determinants of decrease in PAI-1. The altered diurnal fluctuation of PAI-1, especially in T2D with CAD, might be strongly influenced by a prolonged exposure to hyperinsulinemia in the settings of increased IR and abdominal obesity, facilitating altogether an accelerated atherosclerosis. © 2015 Katarina Lalić et al. - Some of the metrics are blocked by yourconsent settings
Publication Altered daytime fluctuation pattern of plasminogen activator inhibitor 1 in type 2 diabetes patients with coronary artery disease: A strong association with persistently elevated plasma insulin, increased insulin resistance, and abdominal obesity(2015) ;Lalić, Katarina (13702563300) ;Jotić, Aleksandra (13702545200) ;Rajković, Nataša (13702670500) ;Singh, Sandra (16022873000) ;Stošić, Ljubica (57205884711) ;Popović, Ljiljana (7004316275) ;Lukić, Ljiljana (24073403700) ;Miličić, Tanja (24073432600) ;Seferović, Jelena P. (23486982900) ;Maćešić, Marija (26967836100) ;Stanarčić, Jelena (59663037000) ;Čivčić, Milorad (18436145000) ;Kadić, Iva (56674542000)Lalić, Nebojša M. (13702597500)This study was aimed at investigating daily fluctuation of PAI-1 levels in relation to insulin resistance (IR) and daily profile of plasma insulin and glucose levels in 26 type 2 diabetic (T2D) patients with coronary artery disease (CAD) (group A), 10 T2D patients without CAD (group B), 12 nondiabetics with CAD (group C), and 12 healthy controls (group D). The percentage of PAI-1 decrease was lower in group A versus group B (4.4 ± 2.7 versus 35.0 ± 5.4%; P<0.05) and in C versus D (14.0 ± 5.8 versus 44.7 ± 3.1%; P<0.001). HOMA-IR was higher in group A versus group B (P<0.05) and in C versus D (P<0.01). Simultaneously, AUCs of PAI-1 and insulin were higher in group A versus group B (P<0.05) and in C versus D (P<0.01), while AUC of glucose did not differ between groups. In multiple regression analysis waist-to-hip ratio and AUC of insulin were independent determinants of decrease in PAI-1. The altered diurnal fluctuation of PAI-1, especially in T2D with CAD, might be strongly influenced by a prolonged exposure to hyperinsulinemia in the settings of increased IR and abdominal obesity, facilitating altogether an accelerated atherosclerosis. © 2015 Katarina Lalić et al. - Some of the metrics are blocked by yourconsent settings
Publication Cataplexy in a patient treated for prolactinoma: Case report; [Katapleksija kod bolesnice sa prolaktinomom](2017) ;Nikolić-Djurović, Marina (6603668923) ;Pereira, Alberto M. (7402230059) ;Jemuović, Zvezdana (57195299822) ;Pavlović, Dragan (57202824440) ;Janković, Dragana (57195298431) ;Petakov, Milan (7003976693) ;Čivčić, Milorad (18436145000) ;Vasović, Olga (15059749900)Damjanović, Svetozar (7003775804)Introduction. Isolated cataplexy, without the presence of narcolepsy, is a relatively rare condition, and can be regarded as attacks of motor inhibition with loss of muscle tone and areflexia. The diagnosis of cataplexy relies on the clinical presentation and medical history and it is rarely confirmed by video-polygraph. We here described a female patient treated for prolactinoma who developed isolated cataplexy. Case report. A 53-year-old female treated with bromocriptine for a macroprolactinoma presented with sudden episodes of weakness and toneless legs leading to falls and injuries on several occasions. Cardiovascular evaluation was completely normal. Psychiatric evaluation showed no psychotic phenomenology or suicidal ideas. Pituitary imaging showed empty sella with a remnant sellar mass with infraand parasellar extension. Neurological examination revealed mild obstructive sleep hypopnea/apnea. Electroencephalographic monitoring during sleep and awakening did not show appearance of epi potentials. HLA haplotyping was positive for HLADR3,16;DR51;DQ1 allele, confirming a diagnosis of isolated cataplexy. Treatment included tricyclic antidepressants and reduction of bromocriptine dosage with resolution of cataplexy. Conclusion. We reported the first case of isolated cataplexy most probably associated with dopamine agonist treatment for prolactinoma. © 2017, Institut za Vojnomedicinske Naucne Informacije/Documentaciju. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Predictors of subclinical cardiovascular disease in women with polycystic ovary syndrome: Interrelationship of dyslipidemia and arterial blood pressure(2015) ;Macut, Djuro (35557111400) ;Bačević, Marina (56586166600) ;Božić-Antić, Ivana (56016978300) ;Bjekić-Macut, Jelica (54400683700) ;Čivčić, Milorad (18436145000) ;Erceg, Snježana (56585758000) ;Vojnović Milutinović, Danijela (6603782935) ;Stanojlović, Olivera (6602159151) ;Andrić, Zoran (56001235100) ;Kastratović-Kotlica, Biljana (55623374800)Šukilović, Tijana (55256250900)Background. Women with polycystic ovary syndrome (PCOS) could develop subclinical atherosclerosis during life. Purpose. To analyze cardiovascular risk (CVR) factors and their relation to clinical markers of cardiovascular disease (CVD) in respect to their age. Material and Methods. One hundred women with PCOS (26.32 ± 5.26 years, BMI: 24.98 ± 6.38 kg/m2) were compared to 50 respective controls. In all subjects, total cholesterol (TC), HDL-C, LDL-C, triglycerides, TC/HDL-C and TG/HDL-C ratios, glucose, insulin and HOMA index, waist-to-hip ratio (WHR), systolic and diastolic blood pressure (SBP and DBP, resp.), and carotid intima-media thickness (CIMT) were analyzed in respect to their age and level of androgens. Results. PCOS over 30 years had higher WHR (P = 0.008), SBP (P < 0.001), DBP (P < 0.001), TC (P = 0.028), HDL-C (P = 0.028), LDL-C (P = 0.045), triglycerides (P < 0.001), TC/HDL-C (P < 0.001), and triglycerides/HDL-C (P < 0.001) and had more prevalent hypertension and pronounced CIMT on common carotid arteries even after adjustment for BMI (P = 0.005 and 0.036, resp.). TC/HDL-C and TG/HDL-C were higher in PCOS with the highest quintile of FAI in comparison to those with lower FAI (P = 0.045 and 0.034, resp.). Conclusions. PCOS women older than 30 years irrespective of BMI have the potential for early atherosclerosis mirrored through the elevated lipids/lipid ratios and through changes in blood pressure. © 2015 Djuro Macut et al. - Some of the metrics are blocked by yourconsent settings
Publication Predictors of subclinical cardiovascular disease in women with polycystic ovary syndrome: Interrelationship of dyslipidemia and arterial blood pressure(2015) ;Macut, Djuro (35557111400) ;Bačević, Marina (56586166600) ;Božić-Antić, Ivana (56016978300) ;Bjekić-Macut, Jelica (54400683700) ;Čivčić, Milorad (18436145000) ;Erceg, Snježana (56585758000) ;Vojnović Milutinović, Danijela (6603782935) ;Stanojlović, Olivera (6602159151) ;Andrić, Zoran (56001235100) ;Kastratović-Kotlica, Biljana (55623374800)Šukilović, Tijana (55256250900)Background. Women with polycystic ovary syndrome (PCOS) could develop subclinical atherosclerosis during life. Purpose. To analyze cardiovascular risk (CVR) factors and their relation to clinical markers of cardiovascular disease (CVD) in respect to their age. Material and Methods. One hundred women with PCOS (26.32 ± 5.26 years, BMI: 24.98 ± 6.38 kg/m2) were compared to 50 respective controls. In all subjects, total cholesterol (TC), HDL-C, LDL-C, triglycerides, TC/HDL-C and TG/HDL-C ratios, glucose, insulin and HOMA index, waist-to-hip ratio (WHR), systolic and diastolic blood pressure (SBP and DBP, resp.), and carotid intima-media thickness (CIMT) were analyzed in respect to their age and level of androgens. Results. PCOS over 30 years had higher WHR (P = 0.008), SBP (P < 0.001), DBP (P < 0.001), TC (P = 0.028), HDL-C (P = 0.028), LDL-C (P = 0.045), triglycerides (P < 0.001), TC/HDL-C (P < 0.001), and triglycerides/HDL-C (P < 0.001) and had more prevalent hypertension and pronounced CIMT on common carotid arteries even after adjustment for BMI (P = 0.005 and 0.036, resp.). TC/HDL-C and TG/HDL-C were higher in PCOS with the highest quintile of FAI in comparison to those with lower FAI (P = 0.045 and 0.034, resp.). Conclusions. PCOS women older than 30 years irrespective of BMI have the potential for early atherosclerosis mirrored through the elevated lipids/lipid ratios and through changes in blood pressure. © 2015 Djuro Macut et al.
